Compounding Pharmacy Market Size 2025-2029
The compounding pharmacy market size is forecast to increase by USD 1.74 billion at a CAGR of 2.2% between 2024 and 2029.
- The market is experiencing significant growth, driven primarily by the increasing demand for personalized medications, particularly in the area of Hormone Replacement Therapy (HRT). This trend is fueled by the individualized treatment approach that compounded drugs offer, addressing unique patient needs and preferences that may not be met by mass-produced medications. However, this market is not without challenges. The rising popularity of compounded drugs has also led to concerns over their safety, with instances of contamination and misuse posing significant risks to patient health. As such, regulatory bodies are increasing their scrutiny of compounding practices, implementing stricter guidelines to ensure the safety and efficacy of these medications.
- Companies seeking to capitalize on this market opportunity must prioritize compliance with regulatory requirements and invest in robust quality control measures to mitigate risks and maintain patient trust. Additionally, partnerships with healthcare providers and pharmacy chains can help expand reach and increase market penetration. Overall, the market presents a promising landscape for growth, with opportunities for innovation and strategic partnerships, as long as players can navigate the regulatory landscape and address safety concerns effectively.
What will be the Size of the Compounding Pharmacy Market during the forecast period?
Request Free Sample
- The sterile compounding pharmacy market is experiencing robust growth, fueled by demand for personalized medication solutions and the opioid crisis. Pharmaceutical research and development, including clinical trials, drive innovation in sterile compounding formulations for diverse dosage forms. Patient records and pharmacy analytics enhance patient safety by preventing medication errors, drug interactions, and adverse drug events. State pharmacy boards enforce stringent regulations on pharmacist licensure, compounding techniques, cleanroom technology, and compliance programs.
- Continuing education and stability testing ensure pharmaceutical manufacturing quality and therapeutic equivalence. Pharmaceutical wholesalers and pharmacy supply chain management secure raw materials and finished products, while personal protective equipment and hazardous drug handling protocols prioritize pharmacist safety. Emerging trends like biosimilar medications and precision medicine offer cost-effective solutions, maintaining pharmaceutical quality. Aseptic technique, pharmacodynamic properties, fraud prevention, and pain management advancements ensure compounding standards, driving patient engagement and market expansion in this SEO-optimized landscape
How is this Compounding Pharmacy Industry segmented?
The compounding pharmacy industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- Product
- Topical medications
- Oral medications
- Parenteral medications
- Suppositories
- Mouthwashes
- Ophthalmic preparations
- Nasal preparations
- Otic preparations
- Sterile Compounds
- Others
- Therapeutic Area
- Pain management
- Hormone replacement
- Dermatological applications
- Nutritional supplements
- Specialty drugs
- Pediatric applications
- Veterinary applications
- compounded oncology drug
- Pelvic Pain
- Gastrointestinal Conditions
- Allergy Treatments
- Geography
- North America
- Europe
- APAC
- China
- India
- Japan
- South Korea
- Rest of World
By Product Insights
The topical medications segment is estimated to witness significant growth during the forecast period.
Topical medications play a significant role in treating various skin diseases, encompassing a diverse range of dosage forms such as creams, emulsions, ointments, pastes, and gels. The efficacy of these semi-solid drugs lies in their ability to adhere to the application surface for an extended period, ensuring controlled and sustained release to the targeted area. The ultimate objective is for the drug to penetrate the desired skin layers, typically the viable epidermis or upper dermis, to yield therapeutic benefits. In the realm of pharmaceutical research, precision medicine and patient safety are paramount. Clinical trials meticulously evaluate the safety and efficacy of new drugs, while patient records facilitate personalized treatment plans.
In the context of pain management, topical medications offer an alternative to systemic opioids, which are currently at the heart of the opioid crisis. State pharmacy boards oversee the sterile compounding process to ensure patient safety, while drug development continues to advance, pushing the boundaries of dosage forms and delivery systems. In the quest for optimal patient care, the integration of technology, such as patient records and precision medicine, plays a crucial role. The pharmaceutical industry's focus on innovation and patient safety is evident in the ongoing research and development of topical medications, contributing to the evolving landscape of this market.
Download Free Sample Report
The Topical medications segment was valued at USD 5.84 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 40% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
View Free PDF Sample
The market in North America is experiencing substantial expansion due to several factors. The rising prevalence of chronic diseases, such as heart disease, cancer, diabetes, obesity, and hypertension, which affect over 129 million Americans, is a significant driver. These conditions, identified by the US Department of Health and Human Services as leading causes of death, necessitate the production of customized medications, including pediatric medications and patient-specific dosages. Pharmacy automation and technology advancements are streamlining the manufacturing process, enabling the production of high-quality, non-sterile compounded medications. Reimbursement rates and insurance coverage for these customized treatments are increasingly becoming more accessible, making them more affordable for patients.
Pharmacist consultation services are also gaining popularity, ensuring the accuracy and safety of compounded medications. Stringent regulations and government initiatives are in place to ensure quality assurance and patient safety. companies in the market are investing in research and development to provide innovative solutions for various therapeutic areas, including veterinary compounding and personalized medicine. The market's growth is further fueled by the outsourcing of pharmaceutical manufacturing activities to specialized compounding facilities.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Compounding Pharmacy Industry?
- The increasing prevalence of hormone replacement therapy (HRT) and resulting surge in demand for customized medications are the primary factors fueling the market growth for compounded medications.
- The compounded hormonal replacement therapy (HRT) market is experiencing significant growth due to the increasing awareness and demand for personalized medications. With a focus on medication therapy management, compounding pharmacies provide patient-specific solutions for various health issues, including mood swings, hot flashes, acute depression, osteoporosis, breast and bone health, and erectile longevity. These therapies, which include progesterone after hysterectomy, testosterone replacement, and treatments for infertility, cater to unique dosage requirements. The escalating prevalence of lifestyle-related disorders among the young population, driven by changing lifestyles and rising stress levels, has led to a surge in demand for these therapies.
- However, the high cost of these treatments remains a significant challenge. Pharmacy automation and pharmacist consultations are essential in ensuring quality assurance and optimal patient outcomes. Veterinary compounding is another growing segment, catering to the unique needs of animals. Insurance coverage and reimbursement rates continue to be critical factors influencing market growth. The trend towards personalized medicine further underscores the importance of compounded HRTs in delivering effective and customized treatments.
What are the market trends shaping the Compounding Pharmacy Industry?
- The rising trend in personalized medicines, with their increasing popularity, represents a significant market development in the healthcare industry.
- Compounding pharmacies, which specialize in creating customized medications, are gaining traction due to their role in personalized medicine. These pharmacies contribute to the early detection of diseases and accurate treatment selection, thereby reducing mortality rates. Genetic analysis, facilitated by microarray technology, plays a crucial part in determining an individual's health and susceptibility to chronic diseases like cardiovascular conditions and cancer. The increasing awareness of genetic diseases is fueling the progress of compounding pharmacies, focusing on targeted drug development. In pharmaceutical research, sterile compounding of dosage forms is essential for pain management, particularly during clinical trials.
- Patient safety is paramount in this sector, with state pharmacy boards ensuring adherence to stringent regulations. Precision medicine and pharmaceutical research continue to intertwine, with compounding pharmacies playing a vital role in addressing the opioid crisis by providing alternative pain management solutions.
What challenges does the Compounding Pharmacy Industry face during its growth?
- The unsafe usage of compounded drugs poses a significant challenge to the growth of the industry, necessitating stringent regulations and adherence to rigorous quality control measures.
- Compounded pharmacies face challenges from medication shortages and regulatory changes. Improper compounding techniques, such as contamination during the process and disregard for Good Manufacturing Practices (GMP), pose significant risks, particularly in sterile compounding for intravenous solutions and medications for injection. The US Food and Drug Administration (FDA) issued new guidances on January 7, 2025, affecting the compounding of drugs using bulk substances. These stricter regulations for 503A and 503B pharmacies may limit the compounding of certain medications, potentially decreasing the demand for commonly compounded drugs.
- Inventory management is crucial for compounding pharmacies to maintain a steady supply of custom formulations. Pharmacist-led clinics, third-party payers, robotic dispensing, value-based care, remote patient monitoring, medication reconciliation, and chronic conditions are trends shaping the compounded pharmacy market. Pharmacies must navigate licensing requirements and adapt to these market dynamics to remain competitive.
Exclusive Customer Landscape
The compounding pharmacy market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the compounding pharmacy market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, compounding pharmacy market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
ACPHARM QUEENSLAND Pty Ltd. (Australia) - The company specializes in customized compounded pharmacy solutions, focusing on hormone replacement therapies and pediatric medications. Through advanced pharmaceutical techniques, we create unique formulations tailored to individual patient needs. Our team of experienced pharmacists and researchers ensure the highest quality and efficacy in every compound. By providing personalized medication options, we aim to improve patient outcomes and enhance overall healthcare.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- ACPHARM QUEENSLAND Pty Ltd. (Australia)
- Advance Pharmacy (United States)
- B.Braun SE (Germany)
- Doughertys Pharmacy (United States)
- Fagron NV (Netherlands)
- Fresenius Kabi AG (Germany)
- Institutional Pharmacy Solutions (United States)
- ITC Compounding Pharmacy (United States)
- Lee Silsby Compounding Pharmacy (United States)
- McGuff Co. Inc. (United States)
- Nephron Pharmaceuticals Corp. (United States)
- Olympia Pharmacy (United States)
- PenCol Specialty Pharmacy (United States)
- QuVa Pharma Inc. (United States)
- Rx3 Compounding Pharmacy (United States)
- Triangle Compounding Pharmacy (United States)
- Valor Compounding Pharmacy (United States)
- Village Compounding Pharmacy (United States)
- Wedgewood Village Pharmacy LLC (United States)
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Compounding Pharmacy Market
- The market has witnessed significant developments in recent years, with key players focusing on product launches, technological collaborations, mergers and acquisitions, and geographic expansions to strengthen their market presence. Here are four notable developments:
- In January 2025, Fagron, a leading global provider of pharmacy solutions, announced the launch of its new line of sterile compounded products, Fagron Sterile Compounding Solutions (FSCS). This expansion aims to cater to the growing demand for personalized medicines and meet the specific needs of patients (Fagron Press Release).
- In March 2024, AmerisourceBergen, a leading healthcare solutions company, acquired H.D. Smith, a leading pharmaceutical distributor, to expand its reach in the market. This acquisition will enable AmerisourceBergen to offer a broader range of products and services to its customers (AmerisourceBergen Press Release).
- In December 2023, Paras Chemicals, a leading Indian pharmaceutical company, announced a technological collaboration with Siemens Healthineers to set up a state-of-the-art compounding lab in India. This collaboration will enable Paras Chemicals to produce high-quality compounded medicines using advanced technology, thereby enhancing patient safety and efficacy (Paras Chemicals Press Release).
- In August 2022, PCCA, a leading compounding pharmacy organization, announced the opening of its new compounding facility in Texas, USA. This expansion will help PCCA to meet the increasing demand for compounded medications and provide better access to personalized healthcare solutions for patients (PCCA Press Release).
Research Analyst Overview
The compounding pharmacy market is evolving, driven by medication therapy management, where pharmacists optimize patient care through personalized medicine. Pharmacy automation and robotics enhance sterile compounding efficiency, ensuring quality assurance and regulatory compliance. Pediatric medications, allergy treatment, and hormone replacement therapy address unique needs, while precision medicine and pharmaceutical research fuel innovation. Drug development and clinical trials rely on custom formulations, despite challenges like medication shortages and inventory management. Pharmacist-led clinics and value-based care improve outcomes, supported by remote patient monitoring and medication reconciliation. The opioid crisis drives demand for alternative pain management, while reimbursement rates, insurance coverage, and prescription drug pricing impact accessibility. Compounding pharmacy software and patient education optimize operations. Licensing requirements and safe pharmaceutical ingredients ensure quality. Phage-based bioprocessing innovations address contamination, shaping a dynamic market focused on cost containment, patient safety, and tailored therapies..
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Compounding Pharmacy Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
199
|
|
Base year
|
2024
|
|
Historic period
|
2019-2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 2.2%
|
|
Market growth 2025-2029
|
USD 1.74 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2025(%)
|
2.1
|
|
Key countries
|
US, Canada, France, China, India, Germany, Japan, UK, South Korea, and BrazilUAE
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Compounding Pharmacy Market Research and Growth Report?
- CAGR of the Compounding Pharmacy industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the compounding pharmacy market growth of industry companies
We can help! Our analysts can customize this compounding pharmacy market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Compounding Pharmacy Market 2019 - 2023
- Historic Market Size - Data Table on Global Compounding Pharmacy Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
- 5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on Global Compounding Pharmacy Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share (2024-2029) (%)
- Data Table on Product - Market share (2024-2029) (%)
- Chart on Otic preparations - Market size and forecast (2024-2029) ($ million)
- Data Table on Otic preparations - Market size and forecast (2024-2029) ($ million)
- Chart on Otic preparations - Year-over-year growth (2024-2029) (%)
- Data Table on Otic preparations - Year-over-year growth (2024-2029) (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Sterile Compounds - Market size and forecast (2024-2029) ($ million)
- Data Table on Sterile Compounds - Market size and forecast (2024-2029) ($ million)
- Chart on Sterile Compounds - Year-over-year growth (2024-2029) (%)
- Data Table on Sterile Compounds - Year-over-year growth (2024-2029) (%)
- 8.3 Topical medications - Market size and forecast (2024-2029)
- Chart on Topical medications - Market size and forecast (2024-2029) ($ million)
- Data Table on Topical medications - Market size and forecast (2024-2029) ($ million)
- Chart on Topical medications - Year-over-year growth (2024-2029) (%)
- Data Table on Topical medications - Year-over-year growth (2024-2029) (%)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
- 8.4 Oral medications - Market size and forecast (2024-2029)
- Chart on Oral medications - Market size and forecast (2024-2029) ($ million)
- Data Table on Oral medications - Market size and forecast (2024-2029) ($ million)
- Chart on Oral medications - Year-over-year growth (2024-2029) (%)
- Data Table on Oral medications - Year-over-year growth (2024-2029) (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
- 8.5 Parenteral medications - Market size and forecast (2024-2029)
- Chart on Parenteral medications - Market size and forecast (2024-2029) ($ million)
- Data Table on Parenteral medications - Market size and forecast (2024-2029) ($ million)
- Chart on Parenteral medications - Year-over-year growth (2024-2029) (%)
- Data Table on Parenteral medications - Year-over-year growth (2024-2029) (%)
- 8.6 Suppositories - Market size and forecast (2024-2029)
- Chart on Suppositories - Market size and forecast (2024-2029) ($ million)
- Data Table on Suppositories - Market size and forecast (2024-2029) ($ million)
- Chart on Suppositories - Year-over-year growth (2024-2029) (%)
- Data Table on Suppositories - Year-over-year growth (2024-2029) (%)
- 8.7 Mouthwashes - Market size and forecast (2024-2029)
- Chart on Mouthwashes - Market size and forecast (2024-2029) ($ million)
- Data Table on Mouthwashes - Market size and forecast (2024-2029) ($ million)
- Chart on Mouthwashes - Year-over-year growth (2024-2029) (%)
- Data Table on Mouthwashes - Year-over-year growth (2024-2029) (%)
- 8.8 Ophthalmic preparations - Market size and forecast (2024-2029)
- Chart on Ophthalmic preparations - Market size and forecast (2024-2029) ($ million)
- Data Table on Ophthalmic preparations - Market size and forecast (2024-2029) ($ million)
- Chart on Ophthalmic preparations - Year-over-year growth (2024-2029) (%)
- Data Table on Ophthalmic preparations - Year-over-year growth (2024-2029) (%)
- 8.9 Nasal preparations - Market size and forecast (2024-2029)
- Chart on Nasal preparations - Market size and forecast (2024-2029) ($ million)
- Data Table on Nasal preparations - Market size and forecast (2024-2029) ($ million)
- Chart on Nasal preparations - Year-over-year growth (2024-2029) (%)
- Data Table on Nasal preparations - Year-over-year growth (2024-2029) (%)
9 Market Segmentation by Therapeutic Area
- 9.1 Market segments
- Chart on Therapeutic Area - Market share (2024-2029) (%)
- Data Table on Therapeutic Area - Market share (2024-2029) (%)
- Chart on compounded oncology drug - Market size and forecast (2024-2029) ($ million)
- Data Table on compounded oncology drug - Market size and forecast (2024-2029) ($ million)
- Chart on compounded oncology drug - Year-over-year growth (2024-2029) (%)
- Data Table on compounded oncology drug - Year-over-year growth (2024-2029) (%)
- 9.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- Chart on Pelvic Pain - Market size and forecast (2024-2029) ($ million)
- Data Table on Pelvic Pain - Market size and forecast (2024-2029) ($ million)
- Chart on Pelvic Pain - Year-over-year growth (2024-2029) (%)
- Data Table on Pelvic Pain - Year-over-year growth (2024-2029) (%)
- 9.3 Pain management - Market size and forecast (2024-2029)
- Chart on Pain management - Market size and forecast (2024-2029) ($ million)
- Data Table on Pain management - Market size and forecast (2024-2029) ($ million)
- Chart on Pain management - Year-over-year growth (2024-2029) (%)
- Data Table on Pain management - Year-over-year growth (2024-2029) (%)
- Chart on Gastrointestinal Conditions - Market size and forecast (2024-2029) ($ million)
- Data Table on Gastrointestinal Conditions - Market size and forecast (2024-2029) ($ million)
- Chart on Gastrointestinal Conditions - Year-over-year growth (2024-2029) (%)
- Data Table on Gastrointestinal Conditions - Year-over-year growth (2024-2029) (%)
- 9.4 Hormone replacement - Market size and forecast (2024-2029)
- Chart on Hormone replacement - Market size and forecast (2024-2029) ($ million)
- Data Table on Hormone replacement - Market size and forecast (2024-2029) ($ million)
- Chart on Hormone replacement - Year-over-year growth (2024-2029) (%)
- Data Table on Hormone replacement - Year-over-year growth (2024-2029) (%)
- Chart on Allergy Treatments - Market size and forecast (2024-2029) ($ million)
- Data Table on Allergy Treatments - Market size and forecast (2024-2029) ($ million)
- Chart on Allergy Treatments - Year-over-year growth (2024-2029) (%)
- Data Table on Allergy Treatments - Year-over-year growth (2024-2029) (%)
- 9.5 Dermatological applications - Market size and forecast (2024-2029)
- Chart on Dermatological applications - Market size and forecast (2024-2029) ($ million)
- Data Table on Dermatological applications - Market size and forecast (2024-2029) ($ million)
- Chart on Dermatological applications - Year-over-year growth (2024-2029) (%)
- Data Table on Dermatological applications - Year-over-year growth (2024-2029) (%)
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)
- 9.6 Nutritional supplements - Market size and forecast (2024-2029)
- Chart on Nutritional supplements - Market size and forecast (2024-2029) ($ million)
- Data Table on Nutritional supplements - Market size and forecast (2024-2029) ($ million)
- Chart on Nutritional supplements - Year-over-year growth (2024-2029) (%)
- Data Table on Nutritional supplements - Year-over-year growth (2024-2029) (%)
- 9.7 Specialty drugs - Market size and forecast (2024-2029)
- Chart on Specialty drugs - Market size and forecast (2024-2029) ($ million)
- Data Table on Specialty drugs - Market size and forecast (2024-2029) ($ million)
- Chart on Specialty drugs - Year-over-year growth (2024-2029) (%)
- Data Table on Specialty drugs - Year-over-year growth (2024-2029) (%)
- 9.8 Pediatric applications - Market size and forecast (2024-2029)
- Chart on Pediatric applications - Market size and forecast (2024-2029) ($ million)
- Data Table on Pediatric applications - Market size and forecast (2024-2029) ($ million)
- Chart on Pediatric applications - Year-over-year growth (2024-2029) (%)
- Data Table on Pediatric applications - Year-over-year growth (2024-2029) (%)
- 9.9 Veterinary applications - Market size and forecast (2024-2029)
- Chart on Veterinary applications - Market size and forecast (2024-2029) ($ million)
- Data Table on Veterinary applications - Market size and forecast (2024-2029) ($ million)
- Chart on Veterinary applications - Year-over-year growth (2024-2029) (%)
- Data Table on Veterinary applications - Year-over-year growth (2024-2029) (%)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.9 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.13 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.14 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.15 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
- 11.18 BrazilUAE - Market size and forecast (2024-2029)
- Chart on BrazilUAE - Market size and forecast (2024-2029) ($ million)
- Data Table on BrazilUAE - Market size and forecast (2024-2029) ($ million)
- Chart on BrazilUAE - Year-over-year growth (2024-2029) (%)
- Data Table on BrazilUAE - Year-over-year growth (2024-2029) (%)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Market positioning of companies
- Matrix on companies position and classification
- 14.3 ACPHARM QUEENSLAND Pty Ltd. (Australia)
- ACPHARM QUEENSLAND Pty Ltd. (Australia) - Overview
- ACPHARM QUEENSLAND Pty Ltd. (Australia) - Product / Service
- ACPHARM QUEENSLAND Pty Ltd. (Australia) - Key offerings
- 14.4 Advance Pharmacy (United States)
- Advance Pharmacy (United States) - Overview
- Advance Pharmacy (United States) - Product / Service
- Advance Pharmacy (United States) - Key offerings
- 14.5 B.Braun SE (Germany)
- B.Braun SE (Germany) - Overview
- B.Braun SE (Germany) - Product / Service
- B.Braun SE (Germany) - Key offerings
- 14.6 Doughertys Pharmacy (United States)
- Doughertys Pharmacy (United States) - Overview
- Doughertys Pharmacy (United States) - Product / Service
- Doughertys Pharmacy (United States) - Key offerings
- 14.7 Fagron NV (Netherlands)
- Fagron NV (Netherlands) - Overview
- Fagron NV (Netherlands) - Product / Service
- Fagron NV (Netherlands) - Key offerings
- 14.8 Fresenius Kabi AG (Germany)
- Fresenius Kabi AG (Germany) - Overview
- Fresenius Kabi AG (Germany) - Product / Service
- Fresenius Kabi AG (Germany) - Key offerings
- 14.9 Institutional Pharmacy Solutions (United States)
- Institutional Pharmacy Solutions (United States) - Overview
- Institutional Pharmacy Solutions (United States) - Product / Service
- Institutional Pharmacy Solutions (United States) - Key offerings
- 14.10 ITC Compounding Pharmacy (United States)
- ITC Compounding Pharmacy (United States) - Overview
- ITC Compounding Pharmacy (United States) - Product / Service
- ITC Compounding Pharmacy (United States) - Key offerings
- 14.11 Lee Silsby Compounding Pharmacy (United States)
- Lee Silsby Compounding Pharmacy (United States) - Overview
- Lee Silsby Compounding Pharmacy (United States) - Product / Service
- Lee Silsby Compounding Pharmacy (United States) - Key offerings
- 14.12 McGuff Co. Inc. (United States)
- McGuff Co. Inc. (United States) - Overview
- McGuff Co. Inc. (United States) - Product / Service
- McGuff Co. Inc. (United States) - Key offerings
- 14.13 Nephron Pharmaceuticals Corp. (United States)
- Nephron Pharmaceuticals Corp. (United States) - Overview
- Nephron Pharmaceuticals Corp. (United States) - Product / Service
- Nephron Pharmaceuticals Corp. (United States) - Key offerings
- 14.14 Olympia Pharmacy (United States)
- Olympia Pharmacy (United States) - Overview
- Olympia Pharmacy (United States) - Product / Service
- Olympia Pharmacy (United States) - Key offerings
- 14.15 PenCol Specialty Pharmacy (United States)
- PenCol Specialty Pharmacy (United States) - Overview
- PenCol Specialty Pharmacy (United States) - Product / Service
- PenCol Specialty Pharmacy (United States) - Key offerings
- 14.16 QuVa Pharma Inc. (United States)
- QuVa Pharma Inc. (United States) - Overview
- QuVa Pharma Inc. (United States) - Product / Service
- QuVa Pharma Inc. (United States) - Key offerings
- 14.17 Rx3 Compounding Pharmacy (United States)
- Rx3 Compounding Pharmacy (United States) - Overview
- Rx3 Compounding Pharmacy (United States) - Product / Service
- Rx3 Compounding Pharmacy (United States) - Key offerings
- 14.18 Triangle Compounding Pharmacy (United States)
- Triangle Compounding Pharmacy (United States) - Overview
- Triangle Compounding Pharmacy (United States) - Product / Service
- Triangle Compounding Pharmacy (United States) - Key offerings
- 14.19 Valor Compounding Pharmacy (United States)
- Valor Compounding Pharmacy (United States) - Overview
- Valor Compounding Pharmacy (United States) - Product / Service
- Valor Compounding Pharmacy (United States) - Key offerings
- 14.20 Village Compounding Pharmacy (United States)
- Village Compounding Pharmacy (United States) - Overview
- Village Compounding Pharmacy (United States) - Product / Service
- Village Compounding Pharmacy (United States) - Key offerings
- 14.21 Wedgewood Village Pharmacy LLC (United States)
- Wedgewood Village Pharmacy LLC (United States) - Overview
- Wedgewood Village Pharmacy LLC (United States) - Product / Service
- Wedgewood Village Pharmacy LLC (United States) - Key offerings
- 14.22 ACPHARM QUEENSLAND Pty Ltd.
- ACPHARM QUEENSLAND Pty Ltd. - Overview
- ACPHARM QUEENSLAND Pty Ltd. - Product / Service
- ACPHARM QUEENSLAND Pty Ltd. - Key offerings
- 14.23 Advance Pharmacy
- Advance Pharmacy - Overview
- Advance Pharmacy - Product / Service
- Advance Pharmacy - Key offerings
- 14.24 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- 14.25 Doughertys Pharmacy
- Doughertys Pharmacy - Overview
- Doughertys Pharmacy - Product / Service
- Doughertys Pharmacy - Key offerings
- 14.26 Fagron NV
- Fagron NV - Overview
- Fagron NV - Product / Service
- Fagron NV - Key offerings
- 14.27 Fresenius Kabi AG
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- 14.28 Institutional Pharmacy Solutions
- Institutional Pharmacy Solutions - Overview
- Institutional Pharmacy Solutions - Product / Service
- Institutional Pharmacy Solutions - Key offerings
- 14.29 ITC Compounding Pharmacy
- ITC Compounding Pharmacy - Overview
- ITC Compounding Pharmacy - Product / Service
- ITC Compounding Pharmacy - Key offerings
- 14.30 Lee Silsby Compounding Pharmacy
- Lee Silsby Compounding Pharmacy - Overview
- Lee Silsby Compounding Pharmacy - Product / Service
- Lee Silsby Compounding Pharmacy - Key offerings
- 14.31 McGuff Co. Inc.
- McGuff Co. Inc. - Overview
- McGuff Co. Inc. - Product / Service
- McGuff Co. Inc. - Key offerings
- 14.32 Nephron Pharmaceuticals Corp.
- Nephron Pharmaceuticals Corp. - Overview
- Nephron Pharmaceuticals Corp. - Product / Service
- Nephron Pharmaceuticals Corp. - Key offerings
- 14.33 Olympia Pharmacy
- Olympia Pharmacy - Overview
- Olympia Pharmacy - Product / Service
- Olympia Pharmacy - Key offerings
- 14.34 PenCol Specialty Pharmacy
- PenCol Specialty Pharmacy - Overview
- PenCol Specialty Pharmacy - Product / Service
- PenCol Specialty Pharmacy - Key offerings
- 14.35 QuVa Pharma Inc.
- QuVa Pharma Inc. - Overview
- QuVa Pharma Inc. - Product / Service
- QuVa Pharma Inc. - Key offerings
- 14.36 Rx3 Compounding Pharmacy
- Rx3 Compounding Pharmacy - Overview
- Rx3 Compounding Pharmacy - Product / Service
- Rx3 Compounding Pharmacy - Key offerings
- 14.37 Triangle Compounding Pharmacy
- Triangle Compounding Pharmacy - Overview
- Triangle Compounding Pharmacy - Product / Service
- Triangle Compounding Pharmacy - Key offerings
- 14.38 Valor Compounding Pharmacy
- Valor Compounding Pharmacy - Overview
- Valor Compounding Pharmacy - Product / Service
- Valor Compounding Pharmacy - Key offerings
- 14.39 Village Compounding Pharmacy
- Village Compounding Pharmacy - Overview
- Village Compounding Pharmacy - Product / Service
- Village Compounding Pharmacy - Key offerings
- 14.40 Wedgewood Village Pharmacy LLC
- Wedgewood Village Pharmacy LLC - Overview
- Wedgewood Village Pharmacy LLC - Product / Service
- Wedgewood Village Pharmacy LLC - Key offerings
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
